SPIA
RYTM icon

Steward Partners Investment Advisory’s Rhythm Pharmaceuticals RYTM Stock Holding History

Steward Partners Investment Advisory’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-145
Closed -$3.08K – 7353
2021
Q1 		$3.08K Sell
145
-211
-59% -$6.12K ﹤0.01% 3133
2020
Q4 		$11K Sell
356
-2,268
-86% -$57.6K ﹤0.01% 2286
2020
Q3 		$57K Buy
+2,624
New +$60.2K ﹤0.01% 1447

Other funds holding RYTM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Steward Partners Investment Advisory's RYTM Position: Q2 2021 in Review

Steward Partners Investment Advisory sold out of Rhythm Pharmaceuticals (RYTM) in Q2 2021, closing a stake of 145 shares — an estimated $3.08K sold.

Steward Partners Investment Advisory first reported a position in RYTM in Q3 2020 and held it in 3 quarters. The position peaked at $57K in Q3 2020. 105 funds tracked by Wall St. Rank hold RYTM as of Q2 2021.

  • Steward Partners Investment Advisory reported no remaining Rhythm Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 145 Rhythm Pharmaceuticals shares in Q2 2021, an estimated $3.08K.
  • Steward Partners Investment Advisory first reported a position in Rhythm Pharmaceuticals in Q3 2020 and held it in 3 quarters.
  • Steward Partners Investment Advisory's Rhythm Pharmaceuticals position peaked at $57K in Q3 2020.
  • 105 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2021.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2021, filed 13 Aug 2021.